The future of clinical trials evaluating blood substitutes

JAMA

Volumn 299, Issue 19, 2008, Pages 2324-2326

  Fergusson, Dean A ^a,b,c,d   McIntyre, Lauralyn ^b,c  

^a CDC

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d Epidemiology and Community Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BLOOD DONOR; BLOOD SUBSTITUTION; CARDIOVASCULAR RISK; CLINICAL RESEARCH; EDITORIAL; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HUMAN; MORTALITY; PRIORITY JOURNAL;

EID: 44249101377     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.19.jed80027     Document Type: Editorial

References (17)